Position in DTIL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$79,889
+$23,987 QoQ
Shares Held
10,164
0.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 94 holders
Holding Since
Sep 2023
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $1,902,676 across 11 Biotechnology names. DTIL ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAPR |
Capricor Therapeutics, Inc.
|
223,076 | $876,689 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
916 | $455,004 | |
| 3 | ABCL |
AbCellera Biologics Inc.
|
26,183 | $205,536 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292 | $182,073 | |
| 5 | DTIL |
Precision Biosciences Inc
This page
|
10,164 | $79,889 | |
| 6 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
11,786 | $28,286 | |
| 7 | NMRA |
Neumora Therapeutics, Inc.
|
16,232 | $27,594 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
12,344 | $21,725 |
All Filings in DTIL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $79,889 | 10,164 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $55,902 | 10,164 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $41,741 | 10,034 | Shares | Sole | 2026-02-09 | |
| 2023-12-31 | $4,927 | 13,500 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $4,603 | 13,500 | Shares | Sole | 2023-11-06 | |
| No filing history on record for this holder in this stock. | ||||||